Call Number (LC) Title Results
HE 1.75:OEI-01-06-00301 Memorandum Report : state Medicaid agency referrals to the Office of Inspector General exclusions program 1
HE 1.75:OEI-01-06-00510 External quality reviews in Medicaid managed care 1
HE 1.75:OEI-01-07-00290 Memorandum report : long term care hospitals short-stay outliers 1
HE 1.75:OEI-01-07-00450 Management of information technology contracts at the Food and Drug Administration's Center for Drug Evaluation and Research 1
HE 1.75:OEI-01-08-00100 Medicare Part B billing for ultrasound 1
HE 1.75:OEI-01-08-00110 Adverse event reporting for medical devices 1
HE 1.75:OEI-01-08-00280 Memorandum report : beneficiary appeals in Medicare Advantage 1
HE 1.75:OEI-01-08-00390 Documentation of coverage requirements for Medicare home health claims 1
HE 1.75:OEI-01-08-00510 Challenges to FDA's ability to monitor and inspect foreign clinical trials 1
HE 1.75:OEI-01-08-00540 Midyear formulary changes in Medicare prescription drug plans 1
HE 1.75:OEI-01-08-00590 Adverse events in hospitals : Medicare's responses to alleged serious incidents 1
HE 1.75:OEI-01-09-00180 Memorandum report : the use of payment suspensions to prevent inappropriate Medicare payments 1
HE 1.75:OEI-01-09-00550 Medicaid managed care : fraud and abuse concerns remain despite safeguards 1
HE 1.75:OEI-01-09-00620 Memorandum report : quality improvement organizations' final responses to beneficiary complaints 1
HE 1.75:OEI-01-10-00060 Medicare prescription drug sponsors' training to prevent fraud, waste, and abuse 1
HE 1.75:OEI-01-10-00140 Medicare and Medicaid fraud and abuse training in medical education 1
HE 1.75:OEI-01-10-00460 Limited oversight of home health agency OASIS data 1
HE 1.75:OEI-01-10-00470 Scientific disagreements regarding medical device regulatory decisions 1
HE 1.75:OEI-01-11-00210 Dietary supplements : structure/function claims fail to meet federal requirements 1
HE 1.75:OEI-01-11-00211 Dietary supplements : companies may be difficult to locate in an emergency 1